Plasma	NN	plasma NN PennPOS
CCN2	NN	CCN2 NN PennPOS
(	(	( ( NUPOS
connective-tissue-growth-factor	NN	connective-tissue-growth-factor NN PennPOS
;	:	; : NUPOS
CTGF	NN	Ctgf NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
potential	JJ	potential JJ PennPOS
biomarker	NN	biomarker NN PennPOS
in	IN	in IN PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

BACKGROUND	NN	background NN PennPOS
:	:	: : NUPOS
Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
chronic	JJ	chronic JJ PennPOS
,	,	, , NUPOS
progressive	JJ	progressive JJ PennPOS
and	CC	and cc NUPOS
fatal	JJ	fatal JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
disease	NN	disease NN PennPOS
and	CC	and cc NUPOS
useful	JJ	useful JJ PennPOS
biomarkers	NNS	biomarker NNS PennPOS
are	VBP	be vbb NUPOS
required	VBN	require VBN PennPOS
to	TO	to p-acp NUPOS
diagnose	VB	diagnose VBP PennPOS
and	CC	and cc NUPOS
predict	VB	predict VBP PennPOS
disease	NN	disease NN PennPOS
activity	NN	activity NN PennPOS
.	.	. . NUPOS

CCN2	NN	CCN2 NN PennPOS
(	(	( ( NUPOS
connective-tissue-growth-factor	NN	connective-tissue-growth-factor NN PennPOS
;	:	; : NUPOS
CTGF	NN	Ctgf NN PennPOS
)	)	) ) NUPOS
has	VBZ	have vdz NUPOS
been	VBN	be vbn NUPOS
reported	VBN	report VBN PennPOS
as	IN	as c-acp NUPOS
one	CD	one crd NUPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
key	JJ	key JJ PennPOS
profibrotic	JJ	profibrotic JJ PennPOS
factors	NNS	factor NNS PennPOS
associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
transforming-growth-factor-b	NN	transforming-growth-factor-b NN PennPOS
(	(	( ( NUPOS
TGF-b	NN	TGF-b NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
its	PRP$	its po31 NUPOS
assay	NN	assay NN PennPOS
has	VBZ	have vdz NUPOS
potential	JJ	potential JJ PennPOS
as	IN	as c-acp NUPOS
a	DT	a dt NUPOS
non-invasive	JJ	non-invasive JJ PennPOS
measure	NN	measure NN PennPOS
in	IN	in IN PennPOS
various	JJ	various JJ PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
diseases	NNS	disease NNS PennPOS
.	.	. . NUPOS

Recently	RB	recent av-j NUPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
developed	VBD	develop VBD PennPOS
a	DT	a dt NUPOS
new	JJ	new JJ PennPOS
subtraction	NN	subtraction NN PennPOS
method	NN	method NN PennPOS
for	IN	for c-acp NUPOS
determination	NN	determination NN PennPOS
of	IN	of pp-f NUPOS
plasma	NN	plasma NN PennPOS
CCN2	NN	CCN2 NN PennPOS
levels	NNS	level NNS PennPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
examined	VBD	examine VBD PennPOS
the	DT	the dt NUPOS
utility	NN	utility NN PennPOS
of	IN	of pp-f NUPOS
plasma	NN	plasma NN PennPOS
CCN2	NN	CCN2 NN PennPOS
levels	NNS	level NNS PennPOS
as	IN	as c-acp NUPOS
a	DT	a dt NUPOS
surrogate	JJ	surrogate JJ PennPOS
marker	NN	marker NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

METHODS	NNS	method NNS PennPOS
:	:	: : NUPOS
Plasma	NN	plasma NN PennPOS
CCN2	NN	CCN2 NN PennPOS
levels	NNS	level NNS PennPOS
were	VBD	be vbd NUPOS
calculated	VBN	calculate VBN PennPOS
in	IN	in IN PennPOS
33	CD	33 CD PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
14	CD	14 crd NUPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
non-IPF	JJ	non-ipf JJ PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
interstitial	JJ	interstitial JJ PennPOS
pneumonias	NNS	pneumonia NNS PennPOS
(	(	( ( NUPOS
IIPs	NNS	iip NNS PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
101	CD	101 CD PennPOS
healthy	JJ	healthy JJ PennPOS
volunteers	NNS	volunteer NNS PennPOS
by	IN	by IN PennPOS
sandwich	NN	sandwich NN PennPOS
enzyme-linked	JJ	enzyme-linked JJ PennPOS
immunosorbent	JJ	immunosorbent JJ PennPOS
assay	NN	assay NN PennPOS
(	(	( ( NUPOS
ELISA	NN	elisa NN PennPOS
)	)	) ) NUPOS
using	VBG	use VBG PennPOS
specific	JJ	specific JJ PennPOS
monoclonal	JJ	monoclonal JJ PennPOS
antibodies	NNS	antibody NNS PennPOS
for	IN	for c-acp NUPOS
two	CD	two crd NUPOS
distinct	JJ	distinct JJ PennPOS
epitopes	NNS	epitope NNS PennPOS
of	IN	of pp-f NUPOS
human	JJ	human JJ PennPOS
CCN2	NN	CCN2 NN PennPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
evaluated	VBD	evaluate VBD PennPOS
the	DT	the dt NUPOS
utility	NN	utility NN PennPOS
of	IN	of pp-f NUPOS
plasma	NN	plasma NN PennPOS
CCN2	NN	CCN2 NN PennPOS
levels	NNS	level NNS PennPOS
by	IN	by IN PennPOS
comparison	NN	comparison NN PennPOS
with	IN	with pp NUPOS
clinical	JJ	clinical JJ PennPOS
parameters	NNS	parameter NNS PennPOS
.	.	. . NUPOS

RESULTS	NNS	result NNS PennPOS
:	:	: : NUPOS
Plasma	NN	plasma NN PennPOS
CCN2	NN	CCN2 NN PennPOS
levels	NNS	level NNS PennPOS
were	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
higher	JJR	high JJR PennPOS
in	IN	in IN PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
than	IN	than cs NUPOS
in	IN	in IN PennPOS
those	DT	those d NUPOS
with	IN	with pp NUPOS
non-IPF	JJ	non-ipf JJ PennPOS
IIPs	NNS	iip NNS PennPOS
and	CC	and cc NUPOS
healthy	JJ	healthy JJ PennPOS
volunteers	NNS	volunteer NNS PennPOS
.	.	. . NUPOS

Importantly	RB	important av-j NUPOS
,	,	, , NUPOS
plasma	NN	plasma NN PennPOS
CCN2	NN	CCN2 NN PennPOS
levels	NNS	level NNS PennPOS
showed	VBD	show VBN PennPOS
significantly	RB	significant av-j NUPOS
negative	JJ	negative JJ PennPOS
correlation	NN	correlation NN PennPOS
with	IN	with pp NUPOS
6-month	JJ	6-month JJ PennPOS
change	NN	change NN PennPOS
of	IN	of pp-f NUPOS
forced	JJ	forced JJ PennPOS
vital	JJ	vital JJ PennPOS
capacity	NN	capacity NN PennPOS
(	(	( ( NUPOS
FVC	NN	FVC NN PennPOS
)	)	) ) NUPOS
in	IN	in IN PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

CONCLUSIONS	NNS	conclusion NNS PennPOS
:	:	: : NUPOS
Plasma	NN	plasma NN PennPOS
CCN2	NN	CCN2 NN PennPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
potential	JJ	potential JJ PennPOS
biomarker	NN	biomarker NN PennPOS
for	IN	for c-acp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

